Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Circassia Plans $285 Million IPO to Fund Allergy Vaccines
Circassia Plans $285 Million IPO to Fund Allergy Vaccines
Circassia Plans $285 Million IPO to Fund Allergy Vaccines
Submitted by
admin
on February 6, 2014 - 10:18am
Source:
Bloomberg
News Tags:
Circassia
IPOs
vaccines
allergies
Headline:
Circassia Plans $285 Million IPO to Fund Allergy Vaccines
Do Not Allow Advertisers to Use My Personal information
